Connect your agent to akta.pro and build company lists like this across sectors and geos.
Fifteen US healthcare companies with the most coverage of bankruptcy, liquidation, closures and cash shortfalls in 2026.
— 7 of the 15 are in bankruptcy or liquidation, led by Sangamo, BioXcel and Carbon Health — Sangamo, BioXcel, Carbon Health and Zynex are in Chapter 11, Prospect Medical remains in bankruptcy, and Vicarious Surgical and UCare are liquidating. Providence Health Plan is dissolving without a filing.
— 8 of the 15 are hospitals, clinics and insurers, against 7 drug and device developers — The provider and payer group runs from Hennepin Healthcare and Northern Light to UCare and Providence Health Plan. Hennepin and UCare are both in Minneapolis, and Penobscot and Northern Light are both in Maine.
— Carbon Health had raised $642M before filing Chapter 11, the most on the list — Karyopharm ($637M) and Sangamo ($601M) follow, per akta.pro funding records. Public and nonprofit providers such as Hennepin, Watsonville and Penobscot have no equity funding on record.
Top headquarters state California4 of 15 companies, by headquarters city
Companies in bankruptcy or liquidation 7of 15, as of 26 Oct 2026
Articles analysed 134across 68 distinct outlets, Jan to Oct 2026
Editorial list Coverage: United States, companies Filter: Negative sentiment Window: Jan 1, 2026 – Oct 26, 2026 Ranked by: Incident relevance Source: akta.pro News Signals Compiled: Oct 26, 2026| # | Company name | Firmographics | Funding & investors | What company does | What happened & why | Sources |
|---|---|---|---|---|---|---|
| 01 | Vicarious Surgical vicarioussurgical.com Critical | Founded 2014 Waltham, North America USA | $236M Last raise 2025 | Waltham developer of a single-port robotic system for minimally invasive abdominal surgery. Surgical Robotics & Computer-Assisted Surgery Platforms | Dissolved and liquidated in July 2026 after 12 years without FDA approval, according to October coverage. Why Coverage points to the lack of FDA approval or clinical trials, and a 2021 SPAC listing that did not lead to a product. | 12 sources · 7 outlets |
| 02 | Karyopharm Therapeutics karyopharm.com Critical | Founded 2008 Newton, North America USA | $637M Last raise 2026 | Newton, Massachusetts maker of oral cancer drugs, including the multiple myeloma treatment Xpovio. Gastroenterology & Hepatology Pharmaceuticals | Reported second-quarter results in August 2026 while facing a liquidity crisis, with a $15.8 million loan payment due on 10 September. Why Coverage cites stalled Xpovio sales of $30.8 million in the second quarter and limited cash. | 10 sources · 9 outlets |
| 03 | Sangamo Therapeutics sangamo.com Critical | Founded 1995 Brisbane, North America USA | $601M Last raise 2026 | California genomic medicine company developing zinc finger and capsid delivery technology. Gene Therapy for Rare/Monogenic Diseases | Filed Chapter 11 in June 2026, laid off 51 staff, and in August agreed to sell assets to PTC Therapeutics for $111 million and Eli Lilly for $50… Why Coverage cites a 99% share price fall over five years and only $18 million of cash by March 2025, and Nasdaq delisted it in May. | 8 sources · 7 outlets |
| 04 | BioXcel Therapeutics bioxceltherapeutics.com Critical | Founded 2017 New Haven, North America USA | $233M Last raise 2026 | New Haven biopharma company that sells the agitation treatment Igalmi and develops AI-identified drug candidates. Neurology & CNS Specialty Pharmaceuticals | Filed Chapter 11 in Delaware on 27 August 2026 and agreed to sell substantially all assets to Teva for up to $145 million. Why Coverage cites a liquidity crisis, with liabilities of $100 million to $500 million against assets of $10 million to $50 million. | 10 sources · 9 outlets |
| 05 | Hennepin Healthcare hennepinhealthcare.org Critical | Founded 1871 Minneapolis, North America USA | $1B-$5B Revenue estimate · no funding on record | Public, county-owned safety-net health system in Minneapolis that runs HCMC, the state's busiest trauma center. Public/County Primary Care Clinics | Warned in April and May 2026 that it could close, and Minnesota moved to fund a rescue, with the Senate approving $150 million in April and a $705… Why Coverage cites depleted cash reserves, projected operating losses of $40 million to $50 million this year, and a leadership and governance stalemate. | 16 sources · 10 outlets |
| 06 | Prospect Medical Holding pmh.com Critical | Founded 1996 Los Angeles, North America USA | $1B-$5B Revenue estimate · no funding on record | Los Angeles hospital operator, owned by private equity, that ran acute care and behavioral health facilities in several states. Hospital Shared Services, GPOs & System Support Organizations | Remained in bankruptcy proceedings in 2026, with UConn Health completing its purchase of Waterbury Hospital in March and Prospect still owing… Why A Georgetown case study says the owner and Prospect extracted $658 million in dividends and fees from three states' hospitals. | 14 sources · 13 outlets |
| 07 | Providence Health Plan providencehealthplan.com Critical | Founded 1984 Portland, North America USA | $1B-$5B Revenue estimate · no funding on record | Portland nonprofit health insurer with Medicare, individual and employer plans in Oregon, Washington, California and Montana. Large Group Health Insurance (Mid-Market & National Accounts) | Said in August 2026 that it will shut down completely after a Medicare Advantage transfer deal failed, affecting about 64,000 seniors. Why Coverage cites a $102 million loss last year, rising costs and weak Medicare and Medicaid reimbursement. | 7 sources · 5 outlets |
| 08 | Carbon Health carbonhealth.com Critical | Founded 2015 San Francisco, North America USA | $642M Last raise 2026 | San Francisco operator of more than 90 hybrid in-person and virtual primary and urgent care clinics in eight states. Urgent Care & On-Demand Virtual Visits | Filed Chapter 11 in February 2026 and closed three South Bay clinics, and settled a California Attorney General case in July. Why The bankruptcy coverage gives no cause, and the July settlement concerned California's ban on the corporate practice of medicine. | 6 sources · 6 outlets |
| 09 | Zynex zynex.com Critical | Founded 1996 Englewood, North America USA | $76M Last raise 2025 | Colorado maker of electrotherapy and monitoring devices sold to patients and billed to insurers. Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) | Was in Chapter 11 in Texas with an amended reorganization plan by February 2026, was delisted from Nasdaq, and faced securities class actions in… Why Coverage ties the collapse to an overbilling scheme in which it shipped excessive supplies, and it admitted fraud in a February non-prosecution agreement. | 19 sources · 6 outlets |
| 10 | Lyra Therapeutics lyratherapeutics.com Critical | Founded 2015 Watertown, North America USA | $269M Last raise 2025 | Watertown, Massachusetts clinical-stage biotech developing sinus therapies. Nasal Drug Delivery Devices (Sprays/Powder Devices) | Had trading on Nasdaq suspended on 17 March 2026 and filed to delist in April, after terminating its Waltham sublease for $2.1 million. Why Coverage reports an 85% share price fall but gives no cause. | 7 sources · 4 outlets |
| 11 | Northern Light Health northernlighthealth.org Critical | Founded 1983 Brewer, North America USA | $1B-$5B Revenue estimate · no funding on record | Maine's only integrated nonprofit health system, with nine hospitals and more than 127 locations. Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) | Was reported in April 2026 to have lost money for four consecutive years, with its flagship Eastern Maine Medical Center the main drag. Why Coverage cites expensive advanced services and an operating margin of -8.4% at the flagship hospital in 2024. | 6 sources · 5 outlets |
| 12 | Caribou Biosciences cariboubio.com Critical | Founded 2011 Berkeley, North America USA | $318M Last raise 2023 | Berkeley clinical-stage developer of gene-edited CAR-T and CAR-NK cell therapies. Cell Therapy Developers (Allogeneic/Off-the-shelf) | Announced on 7 October 2026 that it would drop its two remaining CAR-T programs, cut jobs and explore strategic alternatives, with its shares down… Why Coverage cites a lack of capital to run a Phase 3 trial. | 5 sources · 5 outlets |
| 13 | Ucare ucare.org Critical | Founded 1982 Minneapolis, North America USA | $1B-$5B Revenue estimate · no funding on record | Minneapolis nonprofit health plan that covered about 587,000 Minnesotans through Medicaid, Medicare Advantage and individual plans. Integrated Physical-Behavioral-Social Care (Whole-Person) Medicaid Plans | Was in liquidation in August 2026, with another 102 jobs cut as it wound down its Medicaid contracts. Why The sources describe the liquidation but give no cause. | 5 sources · 3 outlets |
| 14 | Watsonville Community Hospital watsonvillehospital.com High | Founded 1895 Watsonville, North America USA | $50M-$100M Revenue estimate · no funding on record | Public 75-bed acute care hospital serving the Pajaro Valley in California. Hospital-Operated Urgent Care Centers | Reported in October 2026 that it had about eight days of cash and might suspend its labor and delivery and neonatal intensive care units. Why Coverage cites a $22.4 million loss in 2025, a daily cash shortfall of $85,000 and a $4 million to $6 million hit from federal HR 1 changes. | 4 sources · 2 outlets |
| 15 | Penobscot Community Health Care nprp.pchc.com High | Founded 1997 Bangor, North America USA | $100M-$250M Revenue estimate · no funding on record | Bangor nonprofit community health center offering medical, dental, behavioral health and pharmacy care. Public/County Primary Care Clinics | Closed its Adult Wellness Center and a Belfast dental clinic in autumn 2026 and said it needed $3 million within two months to avoid service cuts or… Why Coverage describes a funding shortfall and gives no deeper cause. | 5 sources |
Healthcare covers organizations that deliver, pay for or supply care, from hospitals and clinics to insurers, drug developers and medical device makers. Financial distress shows up as bankruptcy, liquidation, delisting, emergency funding requests and the closure of services.
The 15 companies here include safety-net hospitals and health systems, health plans, a clinic operator, clinical-stage biotechs and device makers, so the industry codes below describe a broad cross-section of the sector.
This page tracks US-headquartered organizations only. Two otherwise qualifying biotechs were removed because akta.pro records their headquarters outside the US.
Scope: US-headquartered healthcare companies and organizations with negative Financial Distress & Restructuring coverage between 1 January and 26 October 2026.
NAICS and SIC are global standard industry classifications, shown as returned by akta.pro Company Data for the listed companies. The internal taxonomy is akta.pro's own industry tree: each code links to its akta.pro industry page, and the signal categories this page filters on are listed in the provenance line above.